VC DEALS ANALYSIS: April sustains bull run of big-buck deals
This article was originally published in Clinica
The flow of VC deals continued to hold steady in April, with 22 transactions of $1m and over recorded last month and over $626m raised in total.
You may also be interested in...
It would have been difficult to beat March's unusual bumper harvest, which benefitted from Grail's near-$1bn round, but venture fundraising efforts in April were stymied by the absence of deals beyond the $50m mark.
2016 was the year to break the bull run in venture investment activity, with total deal value and volume failing to surpass that of 2015. However, the IVD sector continued to be the most popular area for investment, and technologies that can help unravel the genomic puzzle behind diseases like cancer were the ones that attracted the big bucks last year and look likely to remain so in 2017.
July's batch of medtech venture financing rounds was a classic example of quantity trumping quality. While deal volume was twice as high as June's, there was a notable absence of meaty transactions.